Skip to content

Insomnia Behavioral Intervention Study

Behavioral Intervention to Reduce Sedative Use in Older Adults With Chronic Insomnia

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05301543
Acronym
IBI
Enrollment
20
Registered
2022-03-29
Start date
2022-01-10
Completion date
2028-05-20
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia

Brief summary

This randomized pilot study (n=20) explores the effects of a behavioral intervention, that includes sleep hygiene improvements, in long-term users of sleeping pills, aiming to alleviate or stabilize symptoms of insomnia, monitor and decrease sleeping pill usage. Adherence will be monitored by an optional smartphone application.

Detailed description

This randomized pilot study has a goal of enrolling 20 study participants. The investigators will examine the effects of a behavioral intervention, that includes sleep hygiene improvements such as regular sleep schedules, with assisted coaching support from the research team. Study participants are long-term users of sleeping pills. The goal is to improve or stabilizie insomnia symptoms and decrease sleeping pill usage. Study participant adherence will be monitored by an optional smartphone application.

Interventions

BEHAVIORALExperimental: Behavioral approach 1

Includes changing sleep habits and cognitions around sleep from a mental level

BEHAVIORALComparator: Behavioral approach 2

Includes changing sleep habits and awarenes of sleep from a perception level

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
55 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age of 55-85 * Use of sleeping pill medication for sleep at least 3 nights a week * Diagnosed with Chronic Insomnia by a physician * Speaks English above a 6th-grade level * Has access to a smartphone and/or smart tablet and can use it * Has regular access to internet

Exclusion criteria

* Presence of major depression or other severe psychopathology (e.g., bipolar disorder, psychosis, alcohol/substance abuse, etc.) * Presence of an acute or severe medical condition which, in the opinion of the research team, would interfere with the study participant's ability to participate in the research study, such as an acute heart attack, recent severe trauma, etc.

Design outcomes

Primary

MeasureTime frameDescription
Sleep Pill Dosage28-day follow-upWe will monitor changes in participants' sleep pill total dosage taken over one week using the sleep diary (which includes a daily question regarding sleeping pills used that night). The usage reduction will be calculated as a percent (total weekly usage at end of study divided by total weekly usage during the baseline week).

Secondary

MeasureTime frameDescription
Sleep Efficiency28-day follow-upSleep efficiency which will be calculated using information from the sleep diary (logged daily from day 0 until day 28).

Countries

United States

Contacts

Primary ContactAlex J Mathew
alex.mathew@pennmedicine.upenn.edu215-596-9715

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026